Ligand validation:8XFI

6L0: (8E)-6,17,28-trihydroxy-1,6,12,17,23,28-hexaazacyclotritriacont-8-ene-2,5,13,16,24,27-hexone

6L0 is a Ligand Of Interest in 8XFI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8XFI_6L0_B_401	89%	13%	0.074	0.952	2.48	1.46	12	6	0	0	100%	1
8XFI_6L0_A_401	83%	12%	0.084	0.941	2.82	1.29	11	6	0	0	100%	1
8XFA_6L0_A_401	93%	19%	0.065	0.959	2.34	1.15	10	2	0	0	100%	1
8XF7_6L0_A_401	91%	21%	0.075	0.961	2.24	1.09	11	2	0	0	100%	1
5JJ5_6L0_A_402	74%	0%	0.114	0.945	3.26	9.23	15	30	0	0	100%	1
6Z8A_6L0_A_904	43%	36%	0.239	0.963	1.96	0.6	3	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.